Michael G Grey Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

RPHM Quotes by TradingView

Michael G Grey is of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of RPHM, which is worth approximately $0. The most recent transaction as insider was on Jul 26, 2023, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

MICHAEL G GREY Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 26 2023
SELL
Bona fide gift
-
50,000 Reduced 100.0%
0 Common Stock
Aug 31 2022
BUY
Exercise of conversion of derivative security
$98,500 $1.97 p/Share
50,000 Added 50.0%
50,000 Common Stock

Also insider at

HZNP
Horizon Therapeutics Public Ltd Co Healthcare
Director
MRTX
Mirati Therapeutics, Inc. Healthcare
BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
SPRB
SPRUCE BIOSCIENCES, INC. Healthcare
Executive Chairman
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
MGG

Michael G Grey

Dublin, L2

Track Institutional and Insider Activities on RPHM

Follow Reneo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

News

Receive news related to Reneo Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RPHM